37101235|t|Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease.
37101235|a|Amyloid PET imaging has been crucial for detecting the accumulation of amyloid beta (Abeta) deposits in the brain and to study Alzheimer's disease (AD). We performed a genome-wide association study on the largest collection of amyloid imaging data (N = 13,409) to date, across multiple ethnicities from multicenter cohorts to identify variants associated with brain amyloidosis and AD risk. We found a strong APOE signal on chr19q.13.32 (top SNP: APOE e4; rs429358; beta = 0.35, SE = 0.01, P = 6.2 x 10-311, MAF = 0.19), driven by APOE e4, and five additional novel associations (APOE epsilon2/rs7412; rs73052335/rs5117, rs1081105, rs438811, and rs4420638) independent of APOE e4. APOE e4 and epsilon2 showed race specific effect with stronger association in Non-Hispanic Whites, with the lowest association in Asians. Besides the APOE, we also identified three other genome-wide loci: ABCA7 (rs12151021/chr19p.13.3; beta = 0.07, SE = 0.01, P = 9.2 x 10-09, MAF = 0.32), CR1 (rs6656401/chr1q.32.2; beta = 0.1, SE = 0.02, P = 2.4 x 10-10, MAF = 0.18) and FERMT2 locus (rs117834516/chr14q.22.1; beta = 0.16, SE = 0.03, P = 1.1 x 10-09, MAF = 0.06) that all colocalized with AD risk. Sex-stratified analyses identified two novel female-specific signals on chr5p.14.1 (rs529007143, beta = 0.79, SE = 0.14, P = 1.4 x 10-08, MAF = 0.006, sex-interaction P = 9.8 x 10-07) and chr11p.15.2 (rs192346166, beta = 0.94, SE = 0.17, P = 3.7 x 10-08, MAF = 0.004, sex-interaction P = 1.3 x 10-03). We also demonstrated that the overall genetic architecture of brain amyloidosis overlaps with that of AD, Frontotemporal Dementia, stroke, and brain structure-related complex human traits. Overall, our results have important implications when estimating the individual risk to a population level, as race and sex will needed to be taken into account. This may affect participant selection for future clinical trials and therapies.
37101235	39	46	amyloid	Disease	MESH:C000718787
37101235	78	95	Alzheimer disease	Disease	MESH:D000544
37101235	168	180	amyloid beta	Gene	351
37101235	182	187	Abeta	Gene	351
37101235	224	243	Alzheimer's disease	Disease	MESH:D000544
37101235	245	247	AD	Disease	MESH:D000544
37101235	324	331	amyloid	Disease	MESH:C000718787
37101235	457	474	brain amyloidosis	Disease	MESH:D000686
37101235	479	481	AD	Disease	MESH:D000544
37101235	506	510	APOE	Gene	348
37101235	521	533	chr19q.13.32	Chromosome	19
37101235	544	548	APOE	Gene	348
37101235	553	561	rs429358	SNP	tmVar:rs429358;VariantGroup:0;CorrespondingGene:348;RS#:429358;CorrespondingSpecies:9606
37101235	628	632	APOE	Gene	348
37101235	691	697	rs7412	SNP	tmVar:rs7412;VariantGroup:11;CorrespondingGene:348;RS#:7412;CorrespondingSpecies:9606
37101235	699	709	rs73052335	SNP	tmVar:rs73052335;VariantGroup:3;CorrespondingGene:341;RS#:73052335;CorrespondingSpecies:9606
37101235	710	716	rs5117	SNP	tmVar:rs5117;VariantGroup:5;CorrespondingGene:341;RS#:5117;CorrespondingSpecies:9606
37101235	718	727	rs1081105	SNP	tmVar:rs1081105;VariantGroup:6;CorrespondingGene:348;RS#:1081105;CorrespondingSpecies:9606
37101235	729	737	rs438811	SNP	tmVar:rs438811;VariantGroup:10;CorrespondingGene:341;RS#:438811;CorrespondingSpecies:9606
37101235	743	752	rs4420638	SNP	tmVar:rs4420638;VariantGroup:7;CorrespondingGene:341;RS#:4420638;CorrespondingSpecies:9606
37101235	769	773	APOE	Gene	348
37101235	778	782	APOE	Gene	348
37101235	928	932	APOE	Gene	348
37101235	983	988	ABCA7	Gene	10347
37101235	990	1000	rs12151021	SNP	tmVar:rs12151021;VariantGroup:1;CorrespondingGene:10347;RS#:12151021;CorrespondingSpecies:9606
37101235	1001	1012	chr19p.13.3	Chromosome	19
37101235	1068	1071	CR1	Gene	1378
37101235	1073	1082	rs6656401	SNP	tmVar:rs6656401;VariantGroup:2;CorrespondingGene:1378;RS#:6656401;CorrespondingSpecies:9606
37101235	1083	1093	chr1q.32.2	Chromosome	1
37101235	1151	1157	FERMT2	Gene	10979
37101235	1165	1176	rs117834516	SNP	tmVar:rs117834516;VariantGroup:9;RS#:117834516
37101235	1177	1188	chr14q.22.1	Chromosome	14
37101235	1269	1271	AD	Disease	MESH:D000544
37101235	1350	1360	chr5p.14.1	Chromosome	5
37101235	1362	1373	rs529007143	SNP	tmVar:rs529007143;VariantGroup:4;RS#:529007143
37101235	1466	1477	chr11p.15.2	Chromosome	11
37101235	1479	1490	rs192346166	SNP	tmVar:rs192346166;VariantGroup:8;RS#:192346166
37101235	1642	1659	brain amyloidosis	Disease	MESH:D000686
37101235	1682	1684	AD	Disease	MESH:D000544
37101235	1686	1709	Frontotemporal Dementia	Disease	MESH:D057180
37101235	1711	1717	stroke	Disease	MESH:D020521
37101235	1755	1760	human	Species	9606
37101235	1947	1958	participant	Species	9606
37101235	Association	MESH:D000544	RS#:1081105;CorrespondingGene:348
37101235	Association	MESH:D000544	RS#:73052335;CorrespondingGene:341
37101235	Association	MESH:D000544	RS#:429358;CorrespondingGene:348
37101235	Association	MESH:D000544	RS#:5117;CorrespondingGene:341
37101235	Association	MESH:D000544	RS#:4420638;CorrespondingGene:341
37101235	Association	MESH:D000544	RS#:438811;CorrespondingGene:341
37101235	Association	MESH:D000544	10347
37101235	Positive_Correlation	MESH:D000544	RS#:12151021;CorrespondingGene:10347
37101235	Positive_Correlation	MESH:D000544	RS#:117834516
37101235	Positive_Correlation	MESH:D000544	RS#:6656401;CorrespondingGene:1378
37101235	Association	MESH:D000544	10979
37101235	Positive_Correlation	MESH:D000544	RS#:529007143
37101235	Association	MESH:D000544	RS#:7412;CorrespondingGene:348
37101235	Association	MESH:D000544	1378
37101235	Association	MESH:D000544	348
37101235	Association	MESH:D000544	341

